Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin. - Suppr | 超能文献

Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.

作者信息

Kraybill W G, Anderson D D, Lindell T D, Fletcher W S

出版信息

Am Surg. 1976 Jul;42(7):467-70.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.

Am Surg. 1976 Jul;42(7):467-70.

2

Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.在晚期胰岛细胞癌治疗中，链脲佐菌素单药与链脲佐菌素加氟尿嘧啶的比较。

N Engl J Med. 1980 Nov 20;303(21):1189-94. doi: 10.1056/NEJM198011203032101.

3

Chemotherapy of metastatic gastrointestinal neoplasms with 5-fluorouracil and streptozotocin.

Cancer Treat Rep. 1977 Oct;61(7):1375-7.

4

[Indications and medical therapy of hypoglycemic beta-insular].

Folia Endocrinol. 1973 Oct;26(5):361-6.

5

Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.

Cancer Treat Rep. 1979 May;63(5):795-6.

6

Diazoxide, encorton and streptozotocin in the treatment of malignant betacytoma.

Acta Med Pol. 1974;15(1):69-77.

7

Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.链脲佐菌素-阿霉素、链脲佐菌素-氟尿嘧啶或氯脲霉素治疗晚期胰岛细胞癌

N Engl J Med. 1992 Feb 20;326(8):519-23. doi: 10.1056/NEJM199202203260804.

8

Adriamycin therapy for advanced insulinoma.阿霉素治疗晚期胰岛素瘤。

J Clin Endocrinol Metab. 1977 Jan;44(1):142-8. doi: 10.1210/jcem-44-1-142.

9

[Is the medical treatment of insulinomas justified? Experience with 9 cases].

Rev Esp Enferm Apar Dig. 1978 Oct 15;54(4):335-50.

10

5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230.5-氟尿嘧啶与结核菌素、链脲佐菌素及5-氟尿嘧啶联合治疗胰腺癌：儿童肿瘤协作组方案7230

J Surg Oncol. 1979;12(3):267-73. doi: 10.1002/jso.2930120311.

引用本文的文献

1

Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism.核碱基和核苷类似物：药代动力学、药效学和代谢水平上的耐药性与再敏化

Cancers (Basel). 2018 Jul 23;10(7):240. doi: 10.3390/cancers10070240.